细菌后生制剂作为减轻心脏代谢疾病的有希望的工具。

Q2 Medicine
Journal of Lipid and Atherosclerosis Pub Date : 2021-05-01 Epub Date: 2021-02-09 DOI:10.12997/jla.2021.10.2.123
Fernando F Anhê, Benjamin A H Jensen, Lais Rossi Perazza, André Tchernof, Jonathan D Schertzer, André Marette
{"title":"细菌后生制剂作为减轻心脏代谢疾病的有希望的工具。","authors":"Fernando F Anhê,&nbsp;Benjamin A H Jensen,&nbsp;Lais Rossi Perazza,&nbsp;André Tchernof,&nbsp;Jonathan D Schertzer,&nbsp;André Marette","doi":"10.12997/jla.2021.10.2.123","DOIUrl":null,"url":null,"abstract":"<p><p>Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects related to the usefulness of bacterial-related molecules strategically positioned as promising treatment strategies for cardiometabolic diseases.</p>","PeriodicalId":16284,"journal":{"name":"Journal of Lipid and Atherosclerosis","volume":"10 2","pages":"123-129"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/bc/jla-10-123.PMC8159759.pdf","citationCount":"8","resultStr":"{\"title\":\"Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases.\",\"authors\":\"Fernando F Anhê,&nbsp;Benjamin A H Jensen,&nbsp;Lais Rossi Perazza,&nbsp;André Tchernof,&nbsp;Jonathan D Schertzer,&nbsp;André Marette\",\"doi\":\"10.12997/jla.2021.10.2.123\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects related to the usefulness of bacterial-related molecules strategically positioned as promising treatment strategies for cardiometabolic diseases.</p>\",\"PeriodicalId\":16284,\"journal\":{\"name\":\"Journal of Lipid and Atherosclerosis\",\"volume\":\"10 2\",\"pages\":\"123-129\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/bc/jla-10-123.PMC8159759.pdf\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Lipid and Atherosclerosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12997/jla.2021.10.2.123\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/2/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Lipid and Atherosclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12997/jla.2021.10.2.123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/2/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 8

摘要

肠道微生物决定宿主免疫代谢的关键特征。某些细菌成分和代谢物(称为后生物)减轻心脏代谢疾病,而其他细菌成分和代谢物则增强病理过程。在这篇综述中,我们讨论了与细菌相关分子的有用性相关的关键方面,这些分子被战略性地定位为有希望的心脏代谢疾病的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases.

Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases.

Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects related to the usefulness of bacterial-related molecules strategically positioned as promising treatment strategies for cardiometabolic diseases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Lipid and Atherosclerosis
Journal of Lipid and Atherosclerosis Medicine-Internal Medicine
CiteScore
6.90
自引率
0.00%
发文量
26
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信